These discoveries are consistent with previous published data showing that the expression of Wnt signaling target genes is significantly enhanced in cells and organoids derived from human familial adenomatous polyposis (FAP) patients carrying different heterozygous APC truncation mutations (FAP1 and FAP2)112. The gene discussed is PTPN13; the disease is Familial adenomatous polyposis.